Fibronolytically active polypeptide
    1.
    发明授权
    Fibronolytically active polypeptide 失效
    纤维蛋白溶解活性多肽

    公开(公告)号:US06261820B1

    公开(公告)日:2001-07-17

    申请号:US09411329

    申请日:1999-10-01

    IPC分类号: C12N948

    摘要: A fibrinolytically active metalloproteinase polypeptide (called “novel acting thrombolytic”) which is useful for blood clot lysis in vivo and methods and materials for its production by recombinant expression are described.

    摘要翻译: 描述了可用于体内血液凝块溶解的纤维蛋白溶解活性金属蛋白酶多肽(称为“新型作用溶栓剂”),以及通过重组表达生产其的方法和材料。

    Binding agents which inhibit myostatin
    6.
    发明授权
    Binding agents which inhibit myostatin 有权
    抑制肌生成抑制素的结合剂

    公开(公告)号:US07928075B2

    公开(公告)日:2011-04-19

    申请号:US12322977

    申请日:2009-02-10

    摘要: The present invention provides binding agents comprising peptides capable of binding myostatin and inhibiting its activity. In one embodiment the binding agent comprises at least one myostatin-binding peptide attached directly or indirectly to at least one vehicle such as a polymer or an Fc domain. The binding agents of the present invention produced increased lean muscle mass when administered to animals and decreased fat to muscle ratios. Therapeutic compositions containing the binding agents of the present invention are useful for treating muscle-wasting disorders and metabolic disorders including diabetes and obesity.

    摘要翻译: 本发明提供了包含能够结合肌生成抑制素并抑制其活性的肽的结合剂。 在一个实施方案中,结合剂包含至少一种与至少一种载体如聚合物或Fc结构域直接或间接连接的肌肉生长抑制素结合肽。 本发明的粘合剂在施用于动物时产生瘦肌肉质量的降低,并且脂肪与肌肉的比例降低。 含有本发明结合剂的治疗组合物可用于治疗肌肉消瘦疾病和代谢紊乱,包括糖尿病和肥胖症。